You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -9.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 8.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | n/a | -1.45 | -3.98p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -3.21 | -8.37p | -17.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -6.01 | -11.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -5.52 | -10.66p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| Destiny Pharma meets recruitment deadline for XF-73 trial Sharecast News | 05 Jan |
|---|---|
| Second Covid wave slows patient recruitment for Destiny Pharma Sharecast News | 12 Oct |
| Destiny Pharma enters collaboration deal with SporeGen Sharecast News | 07 Sep |
| Second Price Monitoring Extn | 10-Feb-21 14:08 |
|---|---|
| Price Monitoring Extension | 10-Feb-21 14:02 |
| Brazilian Patent Granted for XF-73 nasal gel | 03-Feb-21 07:00 |
| Destiny Pharma to join panel discussion at LSX | 02-Feb-21 09:31 |
| Destiny Pharma Appoints Professor Mark Wilcox | 02-Feb-21 09:31 |